Sequenom Granted Continued Listing on Nasdaq

Sequenom has received a letter from Nasdaq's Listing Qualifications Panel stating that it is now compliant with the minimum bid price requirement for continued listing on the Nasdaq National Market, the firm said this week.

The panel has also granted Sequenom an exception until August 15 to file its 10-Q with the Securities and Exchange Commission for the quarter ending June 30, 2006, evidencing shareholders' equity of at least $10 million, the company said.